IL-6, which has been shown to activate Mcl-1 transcription in PCa and cholangiocarcinoma cells through a signal transducer and activator of transcription 3 (Stat3)-dependent mechanism [32], [33], was included as the positive control. The gene discussed is MCL1; the disease is posterior cortical atrophy.